270 results on '"Orens, J."'
Search Results
2. A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death
3. Association of Donor-Derived Cell-Free DNA Levels with the Development of De Novo Donor-Specific Antibodies and Risk of Death in Lung Transplant Recipients
4. Cell-Free DNA to Unveil Potential Mechanisms of Racial Disparities in Lung Transplant
5. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP
6. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation
7. Preoperative Plasma Club (Clara) Cell Secretory Protein Levels Are Associated With Primary Graft Dysfunction After Lung Transplantation
8. National Healthcare Delivery Systems Influence Lung Transplant Outcomes for Cystic Fibrosis
9. Simulated Regionalization of Heart and Lung Transplantation in the United States
10. Elevated Cell Free DNA in Respiratory Viral Infection and Associated Lung Allograft Dysfunction
11. (702) - Cell-Free DNA Exposes Tissue Injury Profiles Leading to Primary Graft Dysfunction
12. (659) - Cell-Free DNA to Unveil Potential Mechanisms of Racial Disparities in Lung Transplant
13. (620) - Association of Donor-Derived Cell-Free DNA Levels with the Development of De Novo Donor-Specific Antibodies and Risk of Death in Lung Transplant Recipients
14. (51) - A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death
15. Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated with High-Grade Primary Graft Dysfunction
16. Impact of AMR Treatment: Responders vs Non-Responders Characteristics
17. Rising PGD Incidence Parallels Increased Recipient Disease Severity
18. Predicting PGD after Lung Transplantation
19. Racial Differences in Immunosuppression and Lung Transplant Outcomes
20. Cell-Free DNA to Monitor Immunosuppression Adequacy in Lung Transplantation
21. Plasma Intercellular Adhesion Molecule‐1 and von Willebrand Factor in Primary Graft Dysfunction After Lung Transplantation
22. (1207) Anellovirus: A Novel Marker for Overimmunosuppression and Risk of Infection in Lung Transplant Recipients
23. High-Quality CMV-Specific CD4+ Memory Is Enriched in the Lung Allograft and Is Associated With Mucosal Viral Control
24. Elevated Plasma Long Pentraxin-3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary Fibrosis
25. Implications of ECMO Bridging and Salvage Strategies on Mortality and PGD
26. Characterization of Respiratory Pathogens in Contemporary Lung Transplant Recipients
27. Donor-Derived-Cell-Free DNA to Identify Primary Graft Dysfunction Patients at Risk of Chronic Lung Allograft Dysfunction
28. Lung Transplantation: DSA to AMR Trajectory
29. To Treat or Not to Treat: DSA Positive Lung Transplant Recipients
30. Lung Transplant Recipients with Severe Primary Graft Dysfunction Requiring ECMO Had Similar Donor-Derived Cell-Free DNA Levels and Lung Function as Matched Controls
31. CD154 Deficiency Uncouples Allograft CD8+ T-Cell Effector Function from Proliferation and Inhibits Murine Airway Obliteration
32. Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation
33. THE EFFECT OF THE LUNG ALLOCATION SCORE ON EARLY OUTCOMES IN LUNG TRANSPLANTATION AMONG INDIVIDUALS WITH CYSTIC FIBROSIS: 540⋆
34. Lung transplantation for pulmonary hypertension
35. Thoracic Organ Transplantation in the United States, 1995–2004
36. Lung mechanics and dyspnea after lung transplantation for chronic airflow obstruction.
37. Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy.
38. Preoperative Epidural Use in Lung Transplantation: A New Frontier in Pain Management?
39. Donor Derived Cell Free DNA is Elevated With Pathogens That are Risk Factors For Chronic Lung Allograft Dysfunction
40. Role of dd-cfDNA in Predicting Early Post-operative Course in Lung Transplant Recipients
41. Antibody-mediated Rejection: Should We Wait for Clinical Diagnosis?
42. Is the New ISHLT Criteria for Pulmonary Antibody-mediated Rejection Also a Severity Indicator?
43. Predicting Risk of Early Readmission in Lung Transplant Recipients Using dd-cfDNA
44. Clinically-unrecognized Allograft Injury is Common After Lung Transplantion
45. Elevated Donor-Derived Cell-Free DNA (ddcfDNA) as an Early Risk Factor for the Development and Persistence of De Novo Donor Specific HLA Antibody
46. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk
47. Relationship of Early Lung Allograft Injury as Measured by Cell Free DNA with Donor and Recipient Characteristics
48. Plasma RIP3 Is Decreased in PGD after Lung Transplantation
49. Redefining Primary Graft Dysfunction after Lung Transplantation
50. Genomic Research Alliance for Transplantation (GRAfT): A Model for Long Term Transplant Studies in Thoracic Organ Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.